Chicago BioCapital Summit

Chicago BioCapital Summit 2024

Video highlights from the 2023 Chicago BioCapital Summit

Join us on Thursday, November 7, 2024!

The Chicago BioCapital Summit is a full day event showcasing Chicago’s extraordinary biotech talent, cutting-edge innovation, and lucrative bioventures.

▸ Register to Attend



LOCATION: Downtown Chicago

EVENT DATE: Thursday, November 7, 2024

EVENT TIME: 8:30 AM – 6:00 PM

EVENT ORGANIZERS: Chicago Biomedical Consortium (CBC) in partnership with Portal Innovations, the Chan Zuckerberg Biohub, and the Tech Transfer offices of CBC and CBC-HITES universities


Quick Links:  Speakers  I   Panelists  I  Fireside Chat  I  Program

SPEAKERS:
Ted LOVE, MD, Chairman, BIO; CEO, Global Blood Therapeutics (Acquired in 2022 by Pfizer)

George Church, PhD, Robert Winthrop Professor of Genetics, Wyss Institute and Harvard Medical School; Serial Entrepreneur


Jim Audia, PhD, EVP Drug Development, Founding Scientist, FLARE Therapeutics

Steven Paul, MD, Venture Partner, Third Rock Ventures; Former CEO, CSO, Karuna Therapeutics (Acquired in 2023 by BMS)


back to top


PANELISTS:

Rima (Shah) Chakrabarti, MD, Venture Partner, KdT

Mira Chaurushiya, MD, Managing Director, Westlake Village BioPartners

Karen Heidelberger, Partner and Chief Partnerships Officer, Deerfield Management

Chris O'Donnell, PhD, Partner, Pfizer Ventures

Anya Scheiss, Managing Partner, J.P. Morgan Life Sciences Private Capital

Steven Squinto, PhD, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital

Dana Watt, Partner, Breakout Ventures

 


Fireside Chat:

Erandi de Silva, PhD, Partner, Drive Capital

Steven Squinto, PhD, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital


back to top


PROGRAM:
MORNING
Welcome and Opening Remarks by Michelle Hoffmann, PhD, CBC Executive Director and CBC Symposium Organizer
Featured Guests:
  • Steven Paul, MD, Venture Partner, Third Rock Ventures; Former CEO, Chief Scientific Officer and President of Research and Development, Karuna Therapeutics Acquired in 2023 by BMS)
  • Jim Audia, PhD, EVP Drug Discovery & Early Development, Founding Scientist, FLARE Therapeutics
Panel 1 – Building biotech ecosystems
Fireside Chat
Distinguished Speaker:
  • George Church, PhD Robert Winthrop Professor of Genetics, Harvard Medical School, co-founder of 50+ companies
AFTERNOON
  • Lunch
  • Hall of Inventions and sponsor talks (3 hours)
Keynote Speaker:
  • Ted Love, MD, Chairman of the Board, Biotechnology Innovation Organization (BIO); Former President & CEO of Global Blood Therapeutics (Acquired in 2022 by Pfizer)
Panel 2 – Connecting the dots: aligning academic discoveries with investors and advisors
Fireside Chat
EVENING
  • Closing Remarks
  • Reception and Networking

 

Register today to attend this exciting event!

▸ Register to Attend

 

back to top


THANK YOU TO OUR SPONSORS:


back to top